bisreports's blog

Brain imaging software offers a valuable addition to the scanned images obtained through these modalities with respect to quantitative analysis. Quantitative insights into the structure, biomarkers, and other subtle abnormalities in the brain are a valuable tool in aiding in a more accurate diagnosis of neurological disorders.

The global  brain disease modalities and software market  report highlights that the market was valued at $13,055.7 million in 2021 and is expected to reach $21,867.6 million by the end of 2031. The market is expected to grow at a CAGR of 5.31% during the forecast period from 2022 to 2031.

The brain Imaging modalities and software market is driven by factors such as the increasing prevalence of neurological disorders, the rising AI integration in the field of medical imaging, and the increasing demand for safer and non-invasive devices for medical imaging. The factors restraining the growth of the market include the high upfront cost of imaging devices and the declining availability of helium.

Global Brain Disease Modalities and Software Market, Overall Coverage

Global Brain Disease Modalities and Software Market Drivers

The market is driven by factors such as the increasing of neurological disorders, the rising AI integration in the prevalence field of medical imaging, and the increasing demand for safer and non-invasive devices for medical imaging.

There has been a paradigm shift in patient preference from invasive to minimally invasive modes of diagnosis as well as treatment. MRI, CT, and PET-CT scans are popular non-invasive methods of medical imaging that produce three-dimensional images of the body to aid in the diagnosis of diseases. Furthermore, there is also a rising preference for safer imaging technologies that employ minimal radiation.

Global Brain Disease Modalities and Software Market Challenges

The factors restraining market growth include the high upfront cost of imaging devices and the declining availability of helium. Hardware devices for medical imaging, such as MRI, CT, and PET-CT scanners, are capital-intensive equipment with a high upfront cost. Lack of affordability is a major factor restraining the growth of the market in emerging economies such as Latin America and Middle East and Africa. Due to the expensive nature of these imaging modalities, there is a considerable lack of accessibility across the population. As a result, the low- and middle-income population usually relies on alternative clinical tests such as blood biomarker tests and cognitive scoring tests as a preliminary method to diagnose neurological disorders.

Furthermore, the shortage of helium globally particularly affects the field of medical imaging in the healthcare sector. MRI scanners require a sufficient quantity of liquid helium, below which the functioning of the scanner is compromised. Therefore, challenges faced by manufacturers of medical imaging modalities associated with the procurement of supercooled liquid helium have a direct effect on the smooth functioning of the machine, thereby hindering the growth of the market.

Global Brain Disease Modalities and Software Market Opportunities

The opportunity for growth of the global brain disease modalities and software market lies in the integration of imaging solutions with novel biomarkers to enable diagnosis of a wider range of neurological disorders and integration of 3D amplified MRI, a new technological advancement in the field of brain imaging. .

This new development, ie, 3D amplified MRI, enables physicians to view pulsations of the brain as opposed to a conventional static MRI image. The real-time visualization of brain movement holds significant potential to detect hard-to-find abnormalities, thereby aiding in the diagnosis process. Companies in the global brain disease modalities and software market can leverage this new technological advancement to gain a competitive edge in the market.

For Custom Research Services:  https://bisresearch.com/our-offerings/custom-research

Impact of COVID-19 on the Global Brain Disease Modalities and Software Market

There was a decline in the demand for neuroimaging services as it was offset by the demand for respiratory imaging and tests for COVID-19 treatment. The need to fulfill the demand for critical supplies for COVID-19 management, such as pulse oximeters, ventilators, and oxygen concentrators, overshadowed the demand and supply of the neuroimaging modalities. Although the neuroimaging market is experiencing overall growth, most of the hospitals have reallocated their budget to stock the resources required to fight COVID-19 as they appear to be more crucial.

The COVID-19 pandemic led to government-mandated travel restrictions, especially during the peak phases, leading to a shifting preference among the global population from physical visits to home-based care. This has led to a further push in demand for wearable imaging scanners that can be used at home. They could potentially decrease the demand for hospital-based imaging devices and software due to the ease of providing diagnoses to the patients.

Key Questions Answered in the Global Brain Disease Modalities and Software Market Report

• How has COVID-19 impacted the adoption of brain imaging modalities and software?

• What are the key regulations governing the brain disease modalities and software market in key regions?

• Which technological developments are projected to have the maximum influence on the global brain disease modalities and software market?

• Who are the leading players holding significant dominance in the global brain disease modalities and software market currently?

• What are the drivers and restraints for the global brain disease modalities and software market?

• Which region has the highest growth rate in the global brain disease modalities and software market?

• Who are the emerging companies in the global brain disease modalities and software market?

Request a Sample -  https://bisresearch.com/requestsample?id=1253type=download

How This Report Can Add Value

Assuming that the reader is a developer of brain disease modalities and software, they will be able to do the following:

• Understand their position as compared to some of the key players in the market

• Stay updated with novel technology integration, features, and the latest developments in the market

• Understand the impact of COVID-19 on the adoption of brain disease modalities and software and the entry barriers as a result of it.

• Gain insights into which regions to target globally based on factors such as the amount of technology integration in medical imaging and the quality of access to affordable medical imaging.

• Gain insights into the end user perception with respect to the adoption of imaging modalities and software

• Identify some of the key players in the market and understand their valuable contribution

BIS Related Studies

Global Point-of-Care Imaging Devices Market

Gene cloning has a critical role in the precision medicine approach, as it confirms the safe and effective application of targeted therapeutics. A majority of players in the global gene cloning services market offer various services such as molecular biology service, cloning and sub cloning service, and mutagenesis service. Also, several diagnostics and pharmaceutical companies are working collaboratively to develop various services for gene cloning for applications in several disease indications in order to enable efficient diagnosis, treatment selection, dosage selection, and treatment monitoring. Applications of gene cloning services primarily include gene synthesis, gene expression, gene therapy, and complementary DNA (cDNA) libraries, among others.

The global gene cloning services market was valued at $1,983.6 million in 2020 and is expected to reach $11,524.4 million by 2031, growing at a CAGR of 17.29% during the forecast period 2021-2031.

Global Gene Cloning Services Market Snapshot

Global Gene Cloning Services Market

Factors fueling the growth of the market include a favorable funding scenario for gene synthesis and cloning services, technological advancement in cloning and subcloning services, and a rise in synergistic activities in the market. Despite rapid advancement in the industry, several key issues need to be addressed to facilitate future growth. Complications associated with large-scale production of cloning vectors and lower transfection efficiency are hampering market growth. Further, some opportunities, such as the rise in demand for gene and cloning services, the limitation of vectors or plasmids, and the development of new economic technologies and services, provide growth to the market.

Market Segmentation

• Service (Gene Synthesis Service, Molecular Biology Service, Custom Cloning Service, and Other Service)

• Gene Type (Standard Gene, Complex Gene, and Other Gene Type)

• Application (Gene Synthesis, Gene Expression, Vaccine Research, Gene Therapy, and Other)

• End User (Academic and Research Institutions, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, and Other End User)
Global Next-Generation Sequencing Market
Global NGS Informatics and Clinical Genomics Market

Regional Segmentation

• North America: U.S. and Canada

• Europe: Germany, France, Italy, U.K., Spain, Switzerland, and Rest-of- Europe

• Asia-Pacific: Japan, China, India, Australia, South Korea, and Rest-of-Asia-Pacific

• Latin America: Brazil, Mexico, and Rest-of-Latin America

• Rest-of-the-World

 

Competitive Landscape

The exponential rise in the prevalence of infectious diseases and various types of cancer on the regional level has created a buzz among companies to invest in advanced technologies such as gene cloning services.

Based on region, Asia-Pacific holds the largest share, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific is anticipated to grow at the fastest CAGR during the forecast period 2021-2031.

 

Market Growth Drivers

• Favorable Funding Scenario for Gene Synthesis and Cloning Services

• Technological Advancement in Cloning and Sub Cloning Services

• Rise in Synergistic Activities in Market

Market Challenges


• Complications Associated with Large-Scale Production of Cloning Vectors

• Lower Transfection Efficiency

Market Opportunities


• Rise in Demand for Gene and Cloning Services

• Limitation of Vectors or Plasmid

• Development of New Economical Technologies and Services

 

Key Questions Answered in this Report:

• How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
o Service (gene synthesis service, molecular biology service, custom cloning service, and other service)
o Gene Type (standard gene, complex gene, and other gene type)
o Application (gene synthesis, gene expression, vaccine research, gene therapy, and other)
o End User (academic and research institutions, clinical laboratories, pharmaceutical and biotechnology companies, and other end user)
o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
• What are the major market drivers, challenges, and opportunities in the global gene cloning services market?
• What are the underlying structures resulting in the emerging trends within the global gene cloning services market?
• How is each segment of the global gene cloning services market expected to grow during the forecast period, and what will be the expected revenue generated by each of the segments by the end of 2031?
• What are the key developmental strategies implemented by the major players to sustain in the competitive market?
• What are the key regulatory implications in developed and developing regions for the gene cloning services market?
• Who are the leading players with significant offerings to the global gene cloning services market? What is the current market dominance for each of these leading players?
• What would be the compound growth rate witnessed by the leading players in the market during the forecast period 2021-2031? Which gene cloning service gene type is anticipated to have the most promising growth?
• What are the key applications in the global gene cloning services market? What are the major segments of these applications? What services are dominating these application segments?
• What are the major services that are employed in the global gene cloning services market? Which is the dominating service?
• Who are the primary end users of the global gene cloning services market? Which is the fastest-growing end-user segment in the global gene cloning services market?
• Who are the key manufacturers in the global gene cloning services market, and what are their contributions? Also, what is the growth potential of each major gene cloning services manufacturer?
• What is the scope of the global gene cloning services market in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World? Which gene cloning service application and end user dominate these regions?
• What are the emerging trends in the global gene cloning services market? How are these trends revolutionizing the diagnostic procedure?
• Which companies are anticipated to be highly disruptive in the future and why?
• What are the regulatory procedures that are required to unify the approval process for emerging gene cloning services? How will these enhance the reimbursement scenario?
• What are the gaps in regularizing optimum gene cloning services adoption in regular healthcare routines? How can these gaps be tackled?

Get Free Sample Report- https://bisresearch.com/requestsample?id=1288type=download

Within the research report, the market has been segmented on the basis of service, gene type, application, end user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

The scope of the report exclusively covers gene cloning services. The study considers molecular biology, gene synthesis service, custom cloning service, and other service in the service segment. The study also takes into consideration the various application offered by key players.

BIS Related Studies

Global Next-Generation Sequencing Market

Global NGS Informatics and Clinical Genomics Market

Capillary electrophoresis also offers prognostic assessments for a wide range of diseases, as well as assistance with treatment selection and monitoring of drug treatment efficacy and is broadly used for nucleic acid analysis and protein analysis applications.Capillary electrophoresis encompasses a rapidly evolving range of consumables, software, and systems that facilitate pathogen detection, viral load estimation, antibiotic and antiviral therapy selection, diagnosis of cancer, and other diseases, by the detection and analysis of proteins and nucleic acid sequences. 

Our healthcare experts have found the Capillary electrophoresis market to be one of the stable markets, and the global market is predicted to grow at a CAGR of 5.66% during the forecast period 2021-2031.

 

Factors fueling the growth of the market include strategic initiatives by key market players and increasing adoption of sequencing in various research fields increase in adoption of personalized medicine; despite rapid advanced industry growth, several key issues need to be addressed to facilitate future growth. Lack of infrastructure and expertise high capital requirement hampering the expansion of global reach uncertain reimbursement scenario further, some of the opportunities, such as government and private support for capillary electrophoresis on large-scale novel diagnostic applications, provide growth to the market.

Market Segmentation

• By Product Type - Instrument, Consumables, and Software

• By Mode - Capillary Gel Electrophoresis (CGE), Capillary Zone Electrophoresis (CZE), Capillary Electro Chromatography (CEC), and Other Mode

• By Application - Nucleic Acid Analysis and Protein Analysis

• By End User - Academic and Research Institutions, Clinical Laboratories, Pharmaceutical and Biotechnology Companies, and Other End User

Regional Segmentation


• North America: U.S., Canada

• Europe: Germany, France, Italy, U.K., Spain, Switzerland, and Rest-of- Europe

• Asia-Pacific: Japan, China, India, Australia, South Korea, and Rest-of-Asia-Pacific

• Latin America: Brazil, Mexico, and Rest-of-Latin America

• Rest-of-the-World

 

Global Capillary Electrophoresis Market Dynamics

blogpost.jpeg 

Competitive Landscape

The exponential rise in the prevalence of infectious diseases and various types of cancer on the global level has created a buzz among companies to invest in advanced technologies such as molecular diagnostics.

Based on region, North America holds the largest share, owing to improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific and Europe regions are anticipated to grow at the fastest CAGR during the forecast period.

 

Key Questions Answered in this Report:

• How is each segment of the market expected to grow during the forecast period 2021-2031, and what is the anticipated revenue to be generated by each segment? Following are the segments:
o Product type (instrument, consumables, and software)
o Mode (capillary gel electrophoresis, capillary zone electrophoresis, and capillary electro chromatography)
o Applications (nucleic acid analysis and protein analysis)
o End user (academic and research institutions, clinical laboratories, pharmaceutical and biotechnology companies, and other end users)
o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
• What are the major market drivers, challenges, and opportunities in the global capillary electrophoresis market?
• What are the underlying structures resulting in the emerging trends within the global capillary electrophoresis market?
• How is each segment of the global capillary electrophoresis market expected to grow during the forecast period, and what will be the expected revenue generated by each of the segments by the end of 2031?
• What are the key developmental strategies implemented by the major players to sustain in the competitive market?
• What are the key regulatory implications in developed and developing regions for capillary electrophoresis?
• Who are the leading players with significant offerings to the global capillary electrophoresis market? What is the current market dominance for each of these leading players?
• What would be the compound growth rate witnessed by the leading players in the market during the forecast period 2021-2031? Which capillary electrophoresis product type is anticipated to have the most promising growth?
• What are the key applications in the global capillary electrophoresis market? What are the major segments of these applications? What technologies are dominating these application segments?
• What are the major technologies that are employed in the global capillary electrophoresis market? Which is the dominating technology?
• Who are the primary end users of the global capillary electrophoresis market? Which is the fastest-growing end-use segment in the global capillary electrophoresis market?
• Who are the key manufacturers in the global capillary electrophoresis market, and what are their contributions? Also, what is the growth potential of each major capillary electrophoresis manufacturer?
• What is the scope of the global capillary electrophoresis market in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World? Which capillary electrophoresis application and end user dominate these regions?
• What are the emerging trends in the global capillary electrophoresis market? How are these trends revolutionizing the diagnostic procedure?
• Which companies are anticipated to be highly disruptive in the future and why?
• What are the regulatory procedures that are required to unify the approval process for emerging capillary electrophoresis? How will these enhance the reimbursement scenario?
• What are the gaps in regularizing optimum capillary electrophoresis adoption in regular healthcare routines? How are these gaps being tackled?

Request Sample - https://bisresearch.com/requestsample?id=1277type=download

Within the research report, the market has been segmented on the basis of product type, mode, application, end user, and region. Each of these segments covers the snapshot of the market over the projected years, the inclination of the market revenue, underlying patterns, and trends by using analytics on the primary and secondary data obtained.

BIS Related Studies

Global Next-Generation Sequencing Market

Global NGS Informatics and Clinical Genomics Market

The global precision medicine market is projected to reach $278.61 billion by 2030, reveals a premium market intelligence report by BIS Research. The study also highlights that the market is set to witness a CAGR of 11.13% during the period between 2020 and 2030. 

The comprehensive study of the global precision medicine market by BIS Research extensively covers the following:

  • Market numbers on micro-segments that are influencing the market 
  • More than 1500 products present in the market
  • Pricing data for more than 500 products
  • Over 350 brands were evaluated 
  • Market share analysis for more than 20 product categories
  • End-user preference data for over 50 end users
  • Detailed global and regional market share analysis including the scrutiny of more than 15 countries 
  • Study of data of more than 60 companies

The detailed report is a compilation of 19 Market Data Tables and 330 Figures spread through 529 Pages and in-depth TOC on "Global Precision Medicine Market"

Besides these parameters, the report also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, segmental analysis, and a visual dashboard of 1400+ products. 

The BIS Research report indicates that the increasing number of genetic tests taken, the growing demand for reliable next-generation sequencing (NGS) results, the rising prevalence of infectious diseases, and the improving funding scenario in the field of precision medicine, among others, are fueling the growth of the market. 

It also highlights the various emerging opportunities, such as growth in emerging nations, capitalization on the high prevalence of cancer, and the evolution of technology in healthcare, that can be leveraged by players operating in the market.  

Additionally, the market intelligence report by BIS Research throws a spotlight on the key industry trends that have a humungous influence in shaping the industry going forward. Some of these trends include the emergence of advanced stabilization products, regulated vs. multimodal analysis, collaborations and partnerships, and several other key trends. 

View the Report from BIS Research: Global Precision Medicine Market

Data from different segments of the market has been analyzed minutely to gain a holistic view of the market. These segments include types of products offered, technologies used, sources used, applications, and regions. Each of these segments is further categorized into sub-segments and micro-segments to compile an in-depth study. 

The technology and ecosystem analysis of the global market includes data analysis on the satisfaction level of different pricing analysis of preferred instruments, accessories and components, and consumables. The study is majorly centered on the sub-segments and micro-segments of the different product markets, such as consumables and instruments. The consumables are further categorized into kits and reagents. 

Emphasizing the dominance of North America in global precision medicine market in 2019 and 2020, Nitish Kumar SinghLead Analyst – BIS Research, states, "In North America, several established diagnostics manufacturers are focusing on expanding their portfolio in NGS-based molecular diagnostics and are collaborating with service providers and pharmaceutical giants to co-market molecular diagnostics solutions with its complementary precision medicine solutions. Moreover, the U.S. government is undertaking a number of initiatives to develop of precision drugs and tests for oncology and non-oncology diseases and provide funds to new startups in the molecular diagnostics and precision medicine field."

Request for a Sample: https://bisresearch.com/requestsample?id=964type=download

Key insights are drawn from in-depth interviews with the key opinion leaders of more than 40 leading companies, market participants, and vendors. The key players profiled in the report include Abbott Laboratories, Almac Group Ltd, Amgen Inc., ANGLE plc, Astellas Pharma Inc., Astra Zeneca PLC, ASURAGEN INC., Bio-Rad Laboratories, Inc., bioMérieux SA., Bristol-Myers Squibb Company, Cardiff Oncology, CETICS Healthcare Technologies GmbH, Danaher Corporation, Eli Lilly and Company Limited, Epic Sciences, Inc., F. Hoffmann-La Roche Ltd, GE Corporation, Gilead Sciences, Inc., GlaxoSmithKline Plc, Illumina, Inc., Intomics A/S, Johnson Johnson Company, Konica Minolta, Inc., Laboratory Corporation of America, MDx Health, Inc., Menarini Silicon Biosystems, Inc., Merck Co., Inc., Myriad Genetics, Inc., Novartis AG, Oracle Corporation, Partek, Inc., Pfizer, Inc., QIAGEN N.V., Quest Diagnostics Inc, Randox Laboratories Ltd., Sanofi SA, Sysmex Corporation, Teva Pharmaceuticals Industries Ltd., and Thermo Fisher Scientific, Inc.

The report also offers strategic recommendations that can help organizations in tracking various products, trends, and technologies that are changing the dynamics of the market. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.

Who should buy this report?

  • Manufacturers of instruments, kits, assays, software, platforms, and consumables
  • Companies in the services market of the precision medicine market

How can this market intelligence report on precision medicine add value to an organization's decision-making process?

  • Aid in product development
  • Help in targeting a segment for launching a new product
  • Offers go to market strategies for different source type
  • Support in diversifying the product portfolio basis risk and progression of technology
  • Help in analyzing technological substitutes and compare the specification
  • Offer tailor-made solutions based on the throughput of different labs
  • Aid in understanding the end-user requirement
  • Assist in exploring the newer application
  • Support in analyzing the competitors' funding scenario

Insightful Questions Covered to Enable Companies take Strategic Decisions

  • What are the estimated and projected numbers for the global precision medicine market for 2020 and 2030?
  • What are the drivers, challenges, and opportunities that are influencing the dynamics of the market?
  • What is the competition layout of the market?
  • What are the parameters on which competition mapping is carried out in the study?
  • Which key development strategies are being followed and implemented by major players to help them sustain in the market?
  • How are different segments of the market expected to perform during the forecast period from 2020 to 2030? The segments included in the comprehensive market study are:
    • product type
    • region
    • technology
    • application
  • Which leading players are currently dominating the market, and what is the expected future scenario?
  • Which companies are anticipated to be highly disruptive in the future, and why?
  • How can the changing dynamics of the market impact the market share of different players operating in the market?
  • What are the strategic recommendations offered in the study?

Related BIS Research Market Reports:

Global NGS Sample Preparation Market - Analysis and Forecast, 2019-2025

Global Next Generation Sequencing (NGS) Market - Analysis and Forecast, 2019-2024

Global Rare Disease Diagnostics Market - Analysis and Forecast, 2018-2025

According to a new market intelligence report by BIS Research, titled "Global Precision Medicine Market- Analysis and Forecast, 2017-2026", the global precision medicine market accounted for $43.59 billion in 2016 and is estimated to reach $141.70 billion by 2026. The market is expected to grow at a compound annual growth rate (CAGR) of 11.23% between the years 2017 and 2026, aided by the adoption of early diagnosis, increased number of adverse drug reactions cases, high prevalence of chronic diseases, and advancements in genetic science, among others.

  

Browse 60 market Data Tables and 278 Figures spread through 580 Pages and in-depth TOC on "Global Precision Medicine Market"

Precision medicine is an emerging approach which enables the investigation of various diseases by evaluating the genetic makeup of an individual subject, thereby, providing a tailored therapeutic treatment to each patient. According to the Personalized Medicine Coalition, the market value of the targeted therapeutic drugs dependent on companion diagnostics was valued to be $25 billion in 2015. Also, the number of precision medicine or personalized medicine drugs that point to specific biomarker has steadily increased from 5 in 2008 to 132 in 2016.

Precision medicine involves a detailed study on patient specific information to diagnose, and characterize the diseases. The concept of precision medicine is rapidly growing in the medical community through tremendous expansion in various advanced technologies such as next generation sequencing, molecular biomarker analysis, bioinformatics, and big data analytics, among others. Comprising of these advanced technologies, precision medicine holds a promising potential to prevent, and treat various diseases such as cancer, cardiovascular, neurology, diabetes, and other diseases, which are burdening the present healthcare system.

 Research Highlights: 

  • Diagnostic tool companies clinical laboratories is dominating the ecosystem segment and expected to reach $49.50 billion by 2026
  • Technologies such as gene sequencing, companion diagnostics, pharmacogenomics, bioinformatics, and big data analytics are foreseen to drive the market growth during the forecast period
  • Oncology is the dominating therapeutic application segment and is expected to grow with a CAGR of 10.44% from 2017 to 2026; it is currently the prime focus in the research and development of precision medicine
  • Cardiovascular segment by region is dominated by North America and is anticipated to grow at a CAGR of 9.93% in the forecast period 2017-2026
  • The North America market is expected to grow over $64.32 billion by 2026 and the market is exceedingly driven by various technological innovations, which has further aided in understanding the biology of various types of cancer. Further, North America majorly comprises of the U.S. and the Canadian market.
  • In Europe, contribution of pharmaceuticals and biotech companies is expected to witness the highest CAGR of 12.53% in the forecast period of 2017-2026 and is expected to outperform diagnostic tools companies and clinical laboratories
  • The Asia Pacific (APAC) precision medicine market, by technology, is currently dominated by molecular diagnostics, and is expected to witness a CAGR of 12.04% in the forecast period 2017-2026

Request for Sample Report: https://bisresearch.com/requestsample?id=469type=downlsoad

 

Competitive Landscape

This market intelligence report provides a multidimensional view of the global precision medicine market in terms of market size and growth potential. This research report aims at answering various aspects of the global precision medicine market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global precision medicine market and assesses the factors governing the same.

Furthermore, the competitive landscape chapter in the report explicates the competitive nature of the global market and enables the reader to get acquainted with the recent market activities, such as market share analysis, Porter's Five Force analysis, product launches, regulatory clearance, and certifications, partnerships, collaborations, business expansions as well as mergers and acquisitions. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market and helps in forming well informed strategic decisions. The research uncovers some of the crucial parameters that must be taken into consideration before entering into the market.

Key Market Players

This report is a meticulous compilation of research on more than 150 players in the market ecosystem and draws upon insights from in-depth interviews with the key opinion leaders of more than 15 leading companies, market participants and vendors. The report also profiles more than 40 companies including several key players, such as Abbott Laboratories, Almac Group, Amgen, Inc., Astellas Pharma, Inc., AstraZeneca PLC, ASURAGEN, INC., bioMerieux SA, BRISTOL-MYERS SQUIBB COMPANY, CETICS Healthcare Technologies GmbH, Eli-Lilly and Company,  F. Hoffmann-La Roche AG, GE Healthcare, Gilead Sciences, Inc., GlaxoSmithKline, IBM Corporation, Illumina, Inc., Intomics A/S, JOHNSON JOHNSON, Laboratory Corporation of America, Merck KGaA, Novartis AG, Pfizer, Inc., QIAGEN, Quest Diagnostics, Randox Laboratories, SANOFI, Teva Pharmaceuticals Limited, and Thermo Fisher Scientific.

Key questions answered in the report: 

  • How did the precision medicine market evolve and what is its scope in the future?
  • What is the approach followed in the development of precision medicine solutions?
  • What are the key areas of interest for the development of precision medicine?
  • What are the major market drivers, challenges, and opportunities in the global precision medicine market?
  • What are the key initiatives and programs launched in the precision medicine market?
  • What are the key developmental strategies which are being implemented by the key players to stand out in this market? Among these strategies, which strategy is currently dominating the market?
  • What are the precision medicine solutions provided by the key companies? What are the key products in pipeline?
  • Who are the key players holding significant number of patents in the precision medicine market?
  • How is the Porter's Five Forces affecting the industry attractiveness in the precision medicine market?
  • What is the role of different stakeholders in value chain for the precision medicine market?
  • What is the total addressable market (TAM), segmental addressable market (SAM) and the potential market opportunity of the global precision medicine market?
  • What is the market share of different leading segments and sub-segments of the market for the years 2017 and 2026?
  • How each of the segments of the global precision medicine market will grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2026?
  • Who are the key players dominating the precision medicine market, in different segments namely the ecosystem players, technologies, and therapeutic applications?
  • What are the influencing factors that may affect the market share of the key players?
  • Who are the leading ecosystem players in the precision medicine market and what is their contribution to the market? What are the key drivers and challenges in each ecosystem player?
  • How has the market been segmented on the basis of technology? Which technology is leading and what is its share in the market? What are the key drivers and challenges in each technology?
  • How has the market been segmented on the basis of therapeutic application? Which therapeutic application is leading and what is its share in the market? What are the key drivers and challenges in each therapeutic application?
  • Which geographical location will contribute to the highest sales of precision medicine solutions and how regions have been further segmented into countries?
  • Who are the key players dominating the precision medicine market, in different regions? What are the key drivers and challenges in each of the geographical regions?  
  • How many countries are covered in each geographical region? Which country is currently dominating the precision medicine market?

Related Reports: 

Global Non-Invasive Prenatal Testing Market, Analysis and Forecast, 2017-2023

Global Liquid Biopsy Market, Analysis and Forecast, 2017-2025

Global Next Generation Sequencing Market, 2017-2026

The global operating room (OR) integration systems market is a huge market comprised of various product types used in an operating room. These include products for visualization, lighting, imaging, OR integration software, and other products such as insufflators, medical printing devices, and OR communication and control systems.

While conventional ORs possessed all the equipment required for an operating room to function, the lack of communication among the various components is one of the major drawbacks that led to the rising interest in implementing integrated operating rooms. Integrated ORs consist of a centralized console that integrates all the components of an OR, such as imaging, visualization, and visualization systems, among others.

The global  operating room integration systems market  report highlights that the market was valued at $11,763.6 million in 2021 and is expected to reach $21,546.1 million by the end of 2031. The market is expected to grow at a CAGR of 6.28% during the forecast period from 2022 to 2031.

OR Integration Systems Market

Global Operating Room Integration Systems Market Drivers

The market is driven by factors such as increased adoption of minimally invasive procedures, rising geriatric population escalating surgical needs, increasing demand to streamline surgical workflow, the shift of TAVI procedures to the integrated environment, and increasing patients' safety concerns in the OR.

There has been a paradigm shift in patient preference from invasive to minimally invasive modes of treatment. A minimally invasive surgery requires a proper arrangement in the operating room, including sophisticated technologies and devices such as communication systems, visualization systems, surgical lights, and surgical camera systems, among others. The operating room integration market caters to the needs of minimally invasive procedures. Therefore, due to the increased adoption of minimally invasive procedures, there has been a boost in the growth of the OR integration market.

Global Operating Room Integration Systems Market Challenges

The factors restraining market growth include the huge capital investment required for integration of the OR. The most significant challenge that medical facilities face is the decision on procurement which is directly related to the cost of integrated OR systems. Technically, the highest degree of integration is required by facilities that perform complex surgical procedures such as cardio and neurosurgery. However, this level of integration can cost an organization from $3-4 million. Therefore, the lack of affordability is a major factor restraining the growth of the market in emerging economies such as Latin America and the Middle East, and Africa. Moreover, the lack of skilled healthcare professionals for OR management in these regions further restrains the market growth.

Furthermore, the challenges associated with retrofitting existing ORS to hybrid OR and the overwhelming number of technologies involved in the complete integration of an operating room acts as restraining factors for the market.

Global Operating Room Integration Systems Market Opportunities

The opportunity for growth of the global operating room integration systems market lies in integrating 4k and 8K technologies in the operating rooms. 4K technology offers significant advantages over traditional HD technology concerning higher resolution and reduced operating times.

Furthermore, the integration of software solutions within the OR is another opportunity for the growth of the market. For instance, the incorporation of artificial intelligence (AI) algorithms such as machine learning and deep learning hold immense potential to transform the way operating rooms function.

 

Global Operating Room  Integration Systems Market Segmentation

 

c7a8482548f458de5b1c82f08f49efb1.png

 

Impact of COVID-19 on the Global Operating Room Integration Systems Market

The COVID-19 pandemic led to a decline in the number of non-essential surgeries performed, which subsequently also impacted the usage of various devices used in operating rooms such as those intended for visualization, display, and imaging, among others. Since operating rooms are a major source of revenue for hospitals, hospitals faced significant losses in revenues owing to the deferral of surgeries. Therefore, as the pandemic led to a surge in demand for critical respiratory equipment and other supplies required for the management of COVID-19, there was a decline in hospital procurement of OR integration products.

 

Key Market Players and Competition Synopsis

Some of the key players operating in the market include Arthrex Inc., CONMED Corporation, Doricon, Dragerwerk AG Co. KGaA, Fisher Paykel Healthcare Corporation Limited, Getinge AB, Hill-Rom Holdings (Trumpf Medical), Integra Life Sciences Holdings Corporation, KARL STORZ Se Co. KG, Olympus Corporation, Richard Wolf GmbH, Skytron, LLC, STERIS plc, Canon Inc., Koninklijke Philips NV, General Electric Company, and Siemens Healthineers AG.

In the past few years, the global operating room integration systems market has witnessed several strategic and technological developments undertaken by the different market players to attain their respective market shares in this emerging domain. Some of the strategies covered in this segment are funding activities, mergers and acquisitions (MA), partnerships, alliances, business expansions, regulatory and legal activities, and new offerings. The preferred strategy for companies has been regulatory and legal activities followed by partnerships and business expansions

 

Key Questions Answered in the Global Operating Room Integration Systems Market Report

• What are the major market drivers, challenges, and opportunities in the global operating room (OR) integration market?
• What are the emerging trends within the global OR integration systems market?
• How is each segment of the global OR integration market expected to grow during the forecast period, and what is the anticipated revenue generated by each of the segments by the end of 2031?
• What are the significant developmental strategies implemented by the major players in order to sustain in the competitive market? What are the key regulatory bodies controlling the entry of OR integration products to the market?
• What are the major OR equipment primarily being integrated with an operating room environment? What is the primary role of different visualization systems in an OR setting?
• Who are the leading players with significant offerings to the global OR integration systems market? What is the current market dominance for each of these leading players?
• What is the expected compound annual growth rate (CAGR) expected to be witnessed by the leading players in the market during the forecast period 2022-2031? Which integration systems are anticipated to have the most promising growth? 
• What are the major country-wise trends pertaining to the adoption of hybrid, integrated, and digital ORs in the global OR integration market?
• Who are the key manufacturers in the global OR integration systems market, and what are their contributions? 
• What is the growth potential of the global OR integration systems market in North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World?
• What are the end user perceptions in the global OR integration systems market?
• What is the patent filing trend in the global OR integration systems market?
• What is the financial analysis and cost considerations in setting up an integrated hybrid operating room in comparison to a conventional OR?
• What is the global OR integration systems market segmentation by application?

 

Request Sample-  https://bisresearch.com/requestsample?id=1274type=download

 How This Report Can Add Value

Assuming that the reader is a developer of OR integration components and software, they will be able to do the following:

• Understand their position as compared to some of the key players in the market 
• Stay updated with novel technology integration, features, and the latest developments in the market
• Understand the impact of COVID-19 on the adoption of integrated OR and the entry barriers as a result of it 
• Gain insights into which regions to target globally based on factors such as the amount of technology integration in operating rooms
• Gain insights into the end-user perception concerning the adoption of operating room integration 
• Identify some of the key players in the market and understand their valuable contribution

 

BIS Related Studies

Global Artificial Intelligence (AI) in Operating Room Market

The growth of the NGS sample preparation market is expected to be driven by the widespread use of NGS in diagnostic laboratories, which has enhanced the accuracy of genetic diagnostics with high consistency. Advanced genetic diagnostic techniques are being used for predictive genetic testing and prenatal diagnosis. As the number of people suffering from genetic disorders is increasing, the efficiency and consistency of the diagnostic screening tests are becoming more crucial. Faster results with minimum errors are required to effectively screen a genetic disorder. The automated NGS sample preparation enhances the consistency and throughput of sample preparation for genetic sequencing. The current market for NGS sample preparation is majorly dominated by manufacturers and service providers such as Thermo Fisher Scientific Inc, Illumina, Inc., BGI Group, Agilent Technologies, Inc., Aurora Biomed, Inc., F. Hoffmann-La Roche Ltd, OPENTRONS, Promega Corporation, Qiagen N.V., Bio-Rad Laboratories, Inc., Eppendorf AG, Oxford Nanopore Technologies plc., Tecan Trading AG , Hamilton Company, New England Biolabs (NEB), Danaher Corporation, and PerkinElmer, Inc.

The global NGS sample preparation market is projected to reach $3,279.3 million by 2026, growing from $1,468.9 million in 2020, at a CAGR of 14.24% during the forecast period 2021-2026.

Improvements in diagnostic methods for the diagnosis of genetic and chronic diseases are highly prioritized all across the globe. There are lots of advancements pertaining to the effective diagnosis of genetic diseases; however, there remains a lack of adoption of technologically advanced equipment in emerging economies. Most of the developing economies in the world still opt for manual instruments in the field of research and diagnostics on account of financial feasibility.

Market Segmentation

• Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components)

• Workflow (Library Preparation, Target Enrichment, Sample Extraction/Isolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (QC), and Pooling)

• Therapeutic Area (Oncology, Infectious Diseases, Human Genetics/Population Genetics, and Others)

• Application (DNA Sequencing, Whole Genome Sequencing, RNA Sequencing, Methylation Sequencing, and Others)

• End User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others)

 

Regional Segmentation

• North America: U.S., Canada

• Europe: Germany, France, U.K., Italy, Spain, Netherlands, Denmark, Belgium, Switzerland, and Rest-of-Europe

• Asia-Pacific: China, Japan, India, South Korea, Australia, Singapore, and Rest-of-Asia-Pacific

• Latin America: Brazil, Mexico, and Rest-of-Latin America

• Rest-of-the-World

 

Market Growth Drivers

• Increasing Use of NGS for Genetic Disorders

• Technological Advancements in NGS Sample Preparation Methods

• Rising Research Funding in the Field of Genomics

 

Market Challenges

• High Cost of Automated NGS Sample Preparation Instruments

• Dearth of Skilled Professionals and Lack of Infrastructure in Emerging Countries

• Stringent Regulatory Standards

 

Market Opportunities

• Adoption of Automated NGS Sample Preparation in the Emerging Markets

• Rising Direct-to-Consumer Testing

 

Key Companies Profiled

Agilent Technologies, Inc., Aurora Biomed Inc., Danaher, Bio-Rad Laboratories, Inc., Eppendorf SE, Opentrons, BGI Group, Promega Corporation, Oxford Nanopore Technologies plc., F. Hoffmann-La Roche Ltd, Tecan Trading AG, Hamilton Company, PerkinElmer Inc., Illumina, Inc., Thermo Fisher Scientific Inc., New England Biolabs, QIAGEN, Pacific Biosciences of California, Inc

For Custom Offerings - https://bisresearch.com/our-offerings/subscriptions

Competitive Landscape

The growth of the NGS sample preparation market can be majorly attributed to major manufacturers of NGS sample preparation products, along with the service providers, who are actively involved in undertaking significant business strategies to translate success in research and development into the commercial clinical setting. Enterprises, led by the market juggernauts, are frequently updating and developing their respective product and service portfolios with innovative solutions to sustain the high competition in the market. Additionally, competitors' activities also include several partnerships, collaborations, and joint ventures to expand individual product and service portfolios along with the global footprint. Based on region, North America holds the largest share in the market owing to the technological advancements in NGS sample preparation methods, improved healthcare infrastructure, rise in per capita income, and improvised reimbursement policies in the region. However, the Asia-Pacific region is anticipated to grow at the fastest CAGR during the forecast period 2021-2026.

 

Key Questions Answered in this Report:

• How is NGS sample preparation revolutionizing oncology?
• What are the major market drivers, challenges, and opportunities in the global NGS sample preparation market?
• What are the underlying structures resulting in the emerging trends within the global NGS sample preparation market?
• How is the COVID-19 pandemic impacting the global NGS sample preparation ecosystem?
• What are the key development strategies that are being implemented by the major players in order to sustain themselves in the competitive market?
• What are the key regulatory implications in developed and developing regions pertaining to the use of NGS sample preparation products?
• What are the potential entry barriers expected to be faced by the companies willing to enter a particular region?
• How is each segment of the market expected to grow during the forecast period 2021-2026, and what is the anticipated revenue to be generated by each of the segments? Following are the segments:
o Product (Consumables, Standalone Automation Instruments, Automated Workstation, Accessories and Components)
o Workflow (Library Preparation, Target Enrichment, Sample Extraction/Isolation, Fragmentation, Sample Quantification, Library Quantification, Quality Control (QC), and Pooling)
o Application (DNA Sequencing, Whole Genome Sequencing, RNA Sequencing, Methylation Sequencing, and Others)
o Therapeutic Area (Oncology, Infectious Diseases, Human Genetics/Population Genetics, and Others)
o End User (Hospitals and Clinics, Academic and Research Institutions, Pharmaceutical and Biotechnology Companies, and Others)
o Region (North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World)
• What are the growth opportunities for the NGS sample preparation companies in the region of their operation?
• Who are the leading players with significant offerings in the global NGS sample preparation market?
• Which companies are anticipated to be highly disruptive in the future, and why?

Request a Sample - https://bisresearch.com/requestsample?id=1249type=download

BIS Related Studies

Transcriptomics Market - A Global and Regional Analysis

Global Next-Generation Sequencing Market

Global NGS Informatics and Clinical Genomics Market

The global dental radiography market report highlights that the market was valued at $2,328.5 million in 2021 and is expected to reach $3,914.8 million by the end of 2031. The market is expected to grow at a CAGR of 5.17% during the forecast period 2022–2031.

Global Dental Radiography Market Drivers

The high prevalence and growing incidences of oral diseases are one of the major factors augmenting the global dental radiography market.  Furthermore, dental radiography imaging systems are witnessing a better field of view in recent years. Extended fields of view are essential for panoramic radiographic imaging to analyze the anatomy of teeth, structural changes in mandible or maxilla, and surrounding soft tissues. The newly launched products in the global dental radiography market encompass necessary features that are required by dentists to carry out basic clinical functions as well as advanced surgical applications. As a result, the growth of oral diagnosis propels the global market for dental radiography.

Global Dental Radiography Market Restraints

The factors restraining the growth of the global dental radiography market include the risks associated with radiation exposure and delay in regulatory approvals. Exposure to ionizing radiations hinders the market’s growth. Moreover, another factor restraining the growth of the global dental radiography market is the high cost associated with dental procedures and equipment.

Global Dental Radiography Market Opportunities

High growth opportunities in emerging economies and the emergence of local companies in Asia-Pacific and the Middle East and Africa hold immense potential for the global dental radiography market growth. In an era of software and digitalization, increased demand for cosmetic dentistry aids in rising the global market for dental radiography.

How This Report Can Add Value

The global ENT devices market is witnessing a high degree of technology integration over the past years. The market comprises various key medical device companies and local companies. The major factors that have a positive impact on the market’s growth include the growing prevalence of hearing disorders, growing technology integration in ENT devices, and growing preference for minimally invasive procedures in ENT specialty.

During COVID-19, the growth of the ENT devices market was negatively impacted, especially in 2020. Although the market recovered quickly in the last quarter of 2020 and the telehealth integration in ENT specialty was a positive impact of COVID-19 on the market.

The global ENT devices market report highlights that the market was valued at $13,799.5 million in 2020 and is expected to reach $25,127.7 million by the end of 2030. The market is expected to grow at a CAGR of 6.12% during the forecast period from 2021 to 2030.

 

Market Segmentation

Global ENT Devices Market (by Procedure)

The global ENT devices market, on the basis of procedure, has been segmented into flexible transoral and transnasal procedures, turbinate reduction and polyp removal, and tympanostomies and vent tube operations.

The flexible transoral and transnasal procedures accounted for the highest share of the market, which can be attributed to advancements in ENT devices. 

Global ENT Devices Market (by End User)

The global ENT devices market, on the basis of end users, has been segmented into hospitals, ambulatory centers, ENT clinics, and others.

Hospitals are at the forefront in terms of ENT devices adoption. The increasing focus on evidence-based care has been one of the strongest drivers for the adoption of ENT.

The growing prominence for outpatient surgeries and rising establishments of ambulatory centers are the leading factors promoting the market's growth for the global ENT devices. The adoption of ENT devices in ambulatory surgical centers can be boosted by prioritizing the increasing demand for minimally invasive surgeries. 

Global ENT Devices Market (by Product Type)

The global ENT devices market, on the basis of product type, has been segmented into diagnostic devices, surgical devices, hearing aids, visualization devices, surgical shavers and debriders, and others.

Hearing aids is the largest product segment in the market, and the trend is projected to continue during the forecast period 2021-2030. Furthermore, surgical devices is projected to be the fastest-growing segment owing to the growing technological advancements in the ENT specialty.

Global ENT Devices Market (by Region)

The different regions covered under the global ENT devices market include North America, Europe, Asia-Pacific, and Rest-of-the-World.

North America dominates the global ENT devices market due to the high prevalence of hearing disorders, growing geriatric population, and high reimbursement rates. The Asia-Pacific ENT devices market is one of the lucrative markets with immense potential for expansion by key players of the global ENT market. The Asia-Pacific ENT devices market is expected to grow at the fastest rate in the forecast period, and this can be attributed to the massive geriatric population base, driving the demand for minimally invasive and non-invasive surgical procedures.

ENT Devices Market Drivers

The factors driving the growth of the market include the growing prevalence of hearing disorders, growing technology integration in ENT devices, and growing preference for minimally invasive procedures in the ENT specialty. The growing prevalence of hearing disorders is the major driver for the market in established and emerging economies. For instance, according to a study published in The Lancet in March 2021, titled, ‘Hearing Loss Prevalence and Years Lived with Disability, 1990–2019: Findings from The Global Burden of Disease Study 2019’, approximately 1.5 billion people suffered from hearing disability globally in 2019. This infers that one in every five people suffered from a form of hearing disability globally. Furthermore, hearing disability is the third common factor for years lived with disability (YLDs) in the global population. The prevalence of hearing loss is projected to grow over the coming decade. According to World Health Organization (WHO), the number of people suffering from disabling hearing loss (DHL) can grow up to 630 million in 2030 and over 900 million by 2050.

Consequently, the rising prevalence of hearing disorders will propel the adoption of hearing aid treatments and advance the growth of the global ENT devices market.

 

ENT Devices Market Challenges

The factors restraining the growth of the global ENT devices market include the high cost of the ENT procedures and the social stigma associated with hearing disorders. The high cost has limited the procedure volume in emerging as well as developed economies. For instance, according to a study published in NCBI in 2018, titled, ‘Health Care Costs and Cost-Effectiveness in Laryngotracheal Stenosis’, treatment of laryngotracheal stenosis (LTS) is one of the expensive ENT procedures. The mean annual cost associated with the disease was $4,080.09. Furthermore, according to another study titled, ‘Comparison of the Financial Burden of Survivors of Head and Neck Cancer with Other Cancer Survivors’, which was published in March 2019, patients getting treatment for head and neck cancer bear higher expenses as compared to other cancer patients. Also, these patients bear higher out-of-pocket costs. Thus, the high cost of the procedures and lack of reimbursement harm the growth of the global ENT devices market.

 

ENT Devices Market Opportunities

Emerging of regional ENT devices manufacturers and synergies between local healthcare authorities and key medical device companies are the major opportunities in the global ENT devices market. The key companies operating in the market can expand in emerging economies by partnering with local healthcare authorities. Such synergies will enable the companies to penetrate the markets effectively and expand their customer base. For instance, Cochlear Limited partnered with The Royal Victorian Eye and Ear Hospital in the U.K. for the development of Geelong Cochlear Care Centre. The center is the first care center of Cochlear Limited in the U.K. and is projected to improve the company’s presence in the country.

For Custom Offerings - https://bisresearch.com/our-offerings/subscriptions

Impact of COVID-19 on the Global ENT Devices Market

During COVID-19, the growth of the ENT devices market was negatively impacted, especially in 2020. Although the ENT facilities continued to operate, the sales of the companies were negatively impacted. Nonetheless, the market grew minimally in 2020 and is projected to witness considerable growth during the forecast period 2021-2030. The increasing technological innovations in the global market and growing adoption in emerging economies are the factors for the growth of the market.

 

Key Market Players and Competition Synopsis

Some of the key players operating in the market include Ambu A/S, Atos Medical Ab, Boston Scientific Corporation, Cochlear Limited, Demant A/S, Eckert Ziegler AG, HOYA Corporation, Johnson Johnson, KARL STORZ SE Co. KG, Medtronic plc, Olympus Corporation, Richard Wolf GmbH, Smith Nephew Plc, Sonova Holding AG, and Stryker Corporation.

Some of the strategies covered in this segment are funding activities, mergers and acquisitions (MAs), partnerships, alliances, and business expansion, regulatory and legal activities, and new offerings. The preferred strategy for companies has been launches of new products or new offerings followed by partnerships, alliances, and business expansion.

 

Request a Sample - https://bisresearch.com/requestsample?id=831type=download

 

BIS Related Reports

Global Radiofrequency-Based Devices Market

Global 4K Medical Imaging Market

Global Next-Generation Visualization and Navigation Systems Market

The global digital biomarkers market is projected to witness significant growth during the forecast period 2022-2028. The high prevalence and growing incidences of chronic diseases and the technological advancements in digital healthcare systems are the key propellers for the growth of the market.

During the COVID-19 pandemic, technological advancements such as the integration of software and artificial intelligence (AI) in wearable devices, rising adoption of mHealth applications, and growing interest in telemedicine and remote patient monitoring systems have all contributed to the market growth for digital biomarkers. The global digital biomarkers market report highlights that the market was valued at $1,808.3 million in 2021 and is expected to reach $16,174.0 million by 2028. The market is expected to grow at a CAGR of 36.06% during the forecast period 2022-2028.

Global Digital Biomarkers Market

Global Digital Biomarkers Market Drivers

Conventional chronic disease diagnostics are very subjective and based on a series of visits. As a result, drug development decisions are based on limited, subjective evidence, resulting in large-scale Phase 3 trials of medications that were unsuccessful. Digital biomarkers can predict the efficacy of a drug more swiftly than a conventional clinical endpoint, thereby accelerating product development in the case of certain therapeutic areas. Moreover, the advancements in digital biomarker technology such as voice-based digital biomarkers, mHealth applications, and the adoption of smart wearable devices are gaining popularity among people.

Furthermore, with the rise in prevalence and incidence of chronic diseases, technological adoption will also increase. As a result, disease diagnosis will become more prevalent, and the global market for digital biomarkers will expand. Governments invest a significant amount of money in healthcare insurance so that the overall healthcare costs can be reduced, and the quality of life and affordability of the treatment can be enhanced.

Impact of COVID-19 on the Global Digital Biomarkers Market

The COVID-19 pandemic had a debilitating impact on the global healthcare ecosystem. Hospitals and clinics faced several challenges, such as lack of resources, high patient influx, and risk of infection among care providers. The market is projected to witness considerable growth during the forecast period 2022-2028. The increasing innovations and product designs in the global market and the growing use in emerging economies are the driving factors for the market's growth.

Market Segmentation

Global Digital Biomarkers Market (by System Components)

The global digital biomarkers market based on system components product type has been segmented into data collection tools and data integration software. Data collection tools have been further segmented into wearables, implantables, and mobile applications.

Global Digital Biomarkers Market (by Type)

The global digital biomarkers market based on product type has been segmented into clinical trials and clinical settings.

Global Digital Biomarkers Market (by Application)

The global digital biomarkers market, based on application, has been segmented into gastrointestinal diseases, sleep and movement disorders, cardiovascular, psychiatric disorders (mood and behavior), neurodegenerative diseases, diabetes, respiratory diseases, and others.

Global Digital Biomarkers Market (by End User)

The global digital biomarkers market based on end user has been segmented into biopharmaceutical companies, providers, and payers.

Global Digital Biomarkers Market (by Region)

The different regions covered under the global digital biomarkers market include North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World.

North America is expected to be the most lucrative region for the global digital biomarkers market due to advanced healthcare infrastructure and a high focus on research and development activities. The Asia-Pacific digital biomarkers market is one of the profitable markets with immense potential for expansion by key players in the global digital biomarkers market. The Asia-Pacific digital biomarkers market is expected to grow at the fastest rate during the forecast period. This can be attributed to the massive geriatric population base, which is driving the increase in the volume of digital biomarkers.

Key Market Players and Competition Synopsis

Some key players operating in the market include AliveCor, Inc., Pear Therapeutics Inc., Abbott, Akili Interactive Labs, Inc., Koninklijke Phillips N.V., Huma, Koneksa Health, Alphabet Inc., and Neurotrack Technologies, Inc.

Some strategies covered in this segment are funding activities, mergers and acquisitions, partnerships, alliances, business expansions, regulatory and legal activities, and new offerings and upgradations.

Key Questions Answered in the Report

•    How has COVID-19 impacted the growth of the global digital biomarkers market?
•    What are the key regulations governing the digital biomarkers market in key regions?
•    What technological developments are projected to have the maximum influence on the global digital biomarkers market?
•    Who are the leading players holding significant dominance in the global digital biomarkers market?
•    What are some of the growth opportunities which market players can capitalize on?
•    What are the drivers and restraints for the global digital biomarkers market?
•    Which region has the highest growth rate in the digital biomarkers market?
•    Which are the fastest growing countries in terms of the global digital biomarkers market?
•    What are the key strategies being adopted by market players in the global digital biomarkers market?

Request Sample for Free - https://bisresearch.com/requestsample?id=1297&type=download

How This Report Can Add Value

Assuming that the reader is a manufacturer of digital biomarkers, the report will assist them in the following ways:

•    Understand their position compared to other key players in the market
•    Stay updated with novel technology integration, features, and the latest developments in the market
•    Understand the impact of COVID-19 on digital biomarkers and the entry barriers for new companies
•    Gain insights into end-user perception concerning the digital biomarkers market
•    Identify some key players in the market and understand their valuable contribution

BIS Related Studies

Global Emerging Mental Health Devices and Platforms Market

Global AI-Enabled Medical Imaging Solutions Market